PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine

The available HBV vaccines based on the HBV surface protein are manufactured in yeasts and demonstrate excellent prophylactic but no therapeutic activity and are thus ineffective against chronic HBV infection. Five different HBV core proteins (HBc)—full length and C-terminally truncated—were used fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dishlers, Andris, Petrovskis, Ivars, Skrastina, Dace, Zarina, Ieva, Lieknina, Ilva, Jansons, Juris, Akopjana, Inara, Zakova, Jelena, Ose, Velta, Sominskaya, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142831/
https://www.ncbi.nlm.nih.gov/pubmed/37110395
http://dx.doi.org/10.3390/microorganisms11040972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142831/
https://www.ncbi.nlm.nih.gov/pubmed/37110395
http://dx.doi.org/10.3390/microorganisms11040972

Ejemplares similares